Comerica Securities »

BioMarin Pharmaceutical shares owned by Comerica Securities

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Comerica Securities from 13F filings

Historical chart of Comerica Securities investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Comerica Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Comerica Securities

Quarter filed Position value Share count Share price at filing
2018-12-31 $272k 3.2k 85.08
2018-09-30 $250k 2.6k 96.90
2018-06-30 $215k 2.3k 94.09

More positions owned by Comerica Securities

iShares S&P 500 Index (IVV)
iShares MSCI EAFE Index Fund (EFA)
iShares Lehman Short Treasury Bond (SHV)
Vanguard Intermediate-Term Bond ETF (BIV)
Spdr S&p 500 Etf (SPY)
iShares S&P MidCap 400 Index (IJH)
Ishares Tr usa min vo (USMV)
iShares S&P SmallCap 600 Index (IJR)
iShares Russell 2000 Index (IWM)
iShares MSCI Emerging Markets Indx (EEM)
iShares S&P 500 Growth Index (IVW)
Ishares U S Etf Tr Short Matur sht mat bd etf (NEAR)
ProShares Credit Suisse 130/30 (CSM)
Vanguard Mid-Cap ETF (VO)
FedEx Corporation (FDX)

View all positions for Comerica Securities

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical